Innovus Pharmaceuticals Inc. (fka INNV)

[kkpennies]

I'm just surprised there is no interim update on revenues (that bothers me).

You didn't see the release this week? http://client.irwebkit.com/innovuspharma/news/2438251

During the second quarter, the company reported a 455% increase in revenue to a record $1 million with $256,000 in operating cash flow. Management stated that the company is on track to reach $5 million in revenue for the full year of 2016 -- and that doesn't include any revenues from FlutiCare™ or other high-profile upcoming product launches.

http://analysis.secfilings.com/articles/66-innovus-innv-beyond-human-platform-reaching-between-20-30-million-people-on-a-monthly-basis-propels-high-margin-sales

Management anticipates that these two products will add an additional $3 million to $4 million in revenue on a yearly basis provided that they are successfully launched on the Beyond Human platform.

Innovus Pharmaceuticals projects earnings $5 million in 2016 based on its existing launched product lines. If management is successful in launching two new products, these revenues could expand by around $1 million in the remainder of the year.

The company’s stock trades with a market capitalization of just $21 million, according to OTC Markets. This would put its price-sales ratio at just 4x – less than many competitors in the space – with a significant double- to triple-digit growth rate.